Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-4508 in locally advanced or metastatic NSCLC
NCT07232849Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-4508 in non-small cell lung cancer (NSCLC), sponsored by Hengrui. Started Dec 2025; status: recruiting.
02
Drugs
HRS-4508
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07232849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07232849.